| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.76B | -1.3% |
| Cost of Revenue | $2.62B | -9.9% |
| Gross Profit | $1.14B | +26.8% |
| R&D Expense | $53.3M | +18.2% |
| SG&A Expense | $633.0M | +6.9% |
| Pre-tax Income | $423.8M | +115.4% |
| Income Tax | $105.1M | +161.2% |
| Net Income | $314.2M | +102.8% |
| EPS (Basic) | $1.60 | +107.8% |
| EPS (Diluted) | $1.57 | +109.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288.6M | +15.3% |
| Accounts Receivable | $534.5M | -11.1% |
| Inventory | $521.5M | -3.9% |
| Current Assets | $1.43B | -4.9% |
| Total Assets | $3.24B | -4.3% |
| Current Liabilities | $782.7M | -8.9% |
| Long-term Debt | $618.8M | -4.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $540.3M | +30.7% |
| Capital Expenditures | $142.3M | +38.4% |
| Investing Cash Flow | -$127.8M | -45.2% |
| Financing Cash Flow | -$373.2M | -14.9% |
| Free Cash Flow | $397.9M | +28.1% |
| Total Liabilities |
| $1.58B |
| -7.6% |
| Stockholders' Equity | $1.68B | -1.1% |